Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Injectable DMAU for Male Contraception: Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of Single IM or SC DMAU Injection Dose Escalation Study in Healthy Male Volunteers

NCT02927210 is registered in ClinicalTrials.gov with Kimberly Myer as lead sponsor.

NCT NCT02927210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02927210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Injectable DMAU for Male Contraception: Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of Single IM or SC DMAU Injection Dose Escalation Study in Healthy Male Volunteers
Lead sponsor
Kimberly Myer
Phase
Phase 1
Overall status
Completed
Start date
February 15, 2017
Completion date
April 29, 2025
Enrollment
106 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy men, male contraception